Rigel Pharmaceuticals Inc
SWB:RI2A
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Rigel Pharmaceuticals Inc
SWB:RI2A
|
US |
|
R
|
Regency Centers Corp
F:RRC
|
US |
|
Microvast Holdings Inc
NASDAQ:MVST
|
US |
|
S
|
Sumitomo Corp
XMUN:SUMA
|
JP |
|
Mizuho Financial Group Inc
TSE:8411
|
JP |
|
A
|
Abbott Laboratories
XHAM:ABL
|
US |
|
C
|
Chocoladefabriken Lindt & Spruengli AG
XBER:LSPP
|
CH |
|
G
|
Globe Life Inc
F:TMJ
|
US |
|
Capital Ltd
OTC:CAPFF
|
UK |
|
Unilever PLC
LSE:ULVR
|
UK |
|
Mitsubishi HC Capital Inc
TSE:8593
|
JP |
|
Japan Tobacco Inc
F:JATA
|
JP |
|
M
|
MS&AD Insurance Group Holdings Inc
XMUN:59M
|
JP |
|
Advanced Info Service PCL
SET:ADVANC
|
TH |
|
Grand Canyon Education Inc
NASDAQ:LOPE
|
US |
|
C
|
Commerzbank AG
DUS:CBK
|
DE |
|
G
|
Globe Life Inc
XMUN:TMJ
|
US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
US |
Wall St Price Targets
RI2A Price Targets Summary
Rigel Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for RI2A is 9.541 EUR with a low forecast of 6.972 EUR and a high forecast of 14.678 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RI2A's stock price target?
Price Target
9.541
EUR
According to Wall Street analysts, the average 1-year price target for RI2A is 9.541 EUR with a low forecast of 6.972 EUR and a high forecast of 14.678 EUR.
What is the Revenue forecast for Rigel Pharmaceuticals Inc?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Revenue has been 45%. The projected CAGR for the next 8 years is 5%.
What is the Gross Profit forecast for Rigel Pharmaceuticals Inc?
Projected CAGR
13%
The compound annual growth rate for Gross Profit over the next 3 years is 13%.
What is the Operating Income forecast for Rigel Pharmaceuticals Inc?
Projected CAGR
3%
The compound annual growth rate for Operating Income over the next 8 years is 3%.
What is the Pre-Tax Income forecast for Rigel Pharmaceuticals Inc?
Projected CAGR
-6%
The compound annual growth rate for Pre-Tax Income over the next 3 years is -6%.
What is the Net Income forecast for Rigel Pharmaceuticals Inc?
Projected CAGR
-6%
The compound annual growth rate for Net Income over the next 8 years is -6%.
